Exelixis Expands Collaboration With Bristol-Myers Squibb
Tuesday, October 12, 2010 - 07:40
in Mathematics & Economics
Pharmaceuticals: New deals accompany the biotech's increased focus on compounds in late-stage development.
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via